Tofacitinib shows promise in scleroderma patients, researchers optimistic for next phase of study
Systemic sclerosis—or scleroderma that affects the skin and internal organs—is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United States. However, systemic sclerosis is ...
Oct 6, 2022
0
39
